Marc Labetoulle
Overview
Explore the profile of Marc Labetoulle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
3443
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roubille S, Escure T, Juillard F, Corpet A, Neplaz R, Binda O, et al.
Proc Natl Acad Sci U S A
. 2024 Nov;
121(49):e2412258121.
PMID: 39589886
Herpes simplex virus 1 (HSV-1) latently infected neurons display diverse patterns in the distribution of the viral genomes within the nucleus. A key pattern involves quiescent HSV-1 genomes sequestered in...
2.
Hoarau G, Best A, Zina-Meziou S, Benali-Abdallah M, Loukil M, Bouvet M, et al.
J Ocul Pharmacol Ther
. 2024 Nov;
41(1):24-32.
PMID: 39501879
Meibomian gland dysfunction (MGD) may cause chronic ocular surface pain (COSP) with a neuropathic component that can significantly impact quality of life and be poorly responsive to conventional treatments of...
3.
Georgel L, Benyoussef A, Berrouiguet S, Guellec D, Carvajal Alegria G, Marhadour T, et al.
RMD Open
. 2024 Oct;
10(4.
PMID: 39357926
Objectives: To develop and validate a web-based ecological momentary assessment (EMA) tool to enhance symptoms monitoring among patients with Sjögren's disease (SjD). Methods: Consecutive adults with SjD were enrolled in...
4.
Gabison E, Rousseau A, Labetoulle M, Gazzah A, Besse B
Prog Retin Eye Res
. 2024 Sep;
103:101302.
PMID: 39303762
Antibody-drug conjugates (ADCs) are designed to maximize cancer cell death with lower cytotoxicity toward noncancerous cells and are an increasingly valuable option for targeted cancer therapies. However, anticancer treatment with...
5.
Couret C, Quintart P, Poinas A, Vibet M, Le Lez M, Labalette P, et al.
Br J Ophthalmol
. 2024 Aug;
109(2):215-222.
PMID: 39168590
Aims: To compare effectiveness of subconjunctival triamcinolone acetonide injections and intravitreal injections of dexamethasone 700 µg implants in reducing central macular thickness (CMT) in uveitic and postoperative macular oedema (ME)....
6.
Paulet E, Contreras V, Galhaut M, Rosenkrands I, Holland M, Burton M, et al.
PLoS Negl Trop Dis
. 2024 Aug;
18(8):e0012388.
PMID: 39093884
Background: Trachoma is a leading cause of infection-related blindness worldwide. This disease is caused by recurrent Chlamydia trachomatis (Ct) infections of the conjunctiva and develops in two phases: i) active...
7.
Chauvier J, Trone M, Gain P, Ollier E, Robert P, Arnould L, et al.
J Ocul Pharmacol Ther
. 2024 Jul;
40(7):410-418.
PMID: 38976493
Multiple myeloma (MM) is the second most common neoplastic blood disease worldwide. Belantamab mafodotin is a new antibody conjugate anti-B-cell maturation antigen effective against refractory myelomas. It induces intracorneal microcysts...
8.
Boucher R, Haigh O, Racy E, Bordonne C, Barreau E, Rousseau A, et al.
Orbit
. 2024 Jun;
44(2):236-245.
PMID: 38913546
Primary tumors of the lacrimal sac (PTLS) are a rare subtype of ocular adnexa tumors, with potentially life-threatening clinical course. There has been growing evidence of human papilloma virus (HPV)...
9.
Nguyen A, Rousseau A, Bodaghi B, Rossi-Semerano L, Galeotti C, Da Cunha E, et al.
Rheumatology (Oxford)
. 2024 May;
64(3):1333-1340.
PMID: 38710493
Introduction: Paediatric granulomatous uveitis (PGU) is rare. In addition, lack of awareness often leads to delayed diagnosis and poor visual outcome. Identifying the underlying cause and deciding how best to...
10.
Boucher R, Boutolleau D, Burrel S, Haigh O, Fernandez J, Vauloup-Fellous C, et al.
Cornea
. 2024 May;
44(1):48-54.
PMID: 38692653
Purpose: The purpose of this study was to describe the efficacy and tolerance of amenamevir (AMNV), an inhibitor of the viral helicase-primase, for the treatment of recalcitrant herpes simplex keratitis...